Several studies [47] have shown that, independently of the familial history, germline disease-causing TP53 alterations are identified in between 3.8% and 7.7% in females with breast carcinoma before 31 years of age, but a Dutch study recently reported a lower rate of 2% [48]. The gene discussed is TP53; the disease is breast carcinoma.